#207 Patient Safety During Prone Positioning, Loss of Resistance Syringe Concerns, and Lidocaine versus Fentanyl for Induction

Unlock the essential strategies for ensuring patient safety during anesthesia in the prone position! On this episode, host Alli Bechtel welcomes Taizoon Dhoon, an associate professor at the University of California, Irvine, who shares his expertise from his recent article in the APSF newsletter. Dhoon sheds light on the often-overlooked risks of prone positioning, detailing the physiological changes and positioning injuries that can arise. This discussion is a treasure trove of knowledge for anesthesia professionals, aiming to elevate patient care practices and enhance collaborative efforts among medical teams.Our journey begins with an in-depth review of recommended practices and preoperative considerations, emphasizing the critical role of thorough exams, patient history evaluations, and cardiac assessments. Discover the actionable steps you can take to improve safety, from pre-surgical planning to additional monitoring during procedures. Whether you're an experienced anesthetist or new to the field, this episode provides the insights and tools you need to navigate the complexities of prone positioning with confidence and precision. Tune in and empower your practice with expert advice and practical recommendations.We are covering two bonus articles to discuss concerns with the Perifix® L.O.R. syringe (B-Braun, Melsungen, Germany) that is used with the loss of resistance (LOR) technique to confirm the epidural space, and we are diving into the literature. Our literature review summary takes you through the 2023 article, "Comparison of the hemodynamic effects o opioid-based versus lidocaine-based induction of anesthesia with propofol in older adults: a randomized controlled trial."For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/207-patient-safety-during-prone-positioning/© 2024, The Anesthesia Patient Safety Foundation

There are no comments yet.

Please log in to write the first comment.